Zhongsheng Pharmaceutical: Two innovative drug projects have been approved for listing, and several innovative drug projects are in the clinical trial stage.

Zhongsheng Pharmaceutical stated during institutional research that the company has established a research and development ecosystem with multiple modes of benign circulation, building a research and development model with independent research and development as the main focus and collaborative research and development as an effective supplement, mainly focusing on diseases such as metabolic diseases and respiratory system diseases. As of now, the company has had 2 innovative drug projects approved for market, with multiple innovative drug projects in the clinical trial stage.